GL1X · GenesisL1 explorer

Research workbench

Solution structure of a calmodulin-target peptide complex by multidimensional NMR

Analyse Solution structure of a calmodulin-target peptide complex by multidimensional… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2BBN
Type
protein
Length
174 residues
Chains
2
Method
solution nmr
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Calmodulin; Myosin light chain kinase
UniProt
P62152, P07313
Ligands
CA
Pockets
4 · best druggability 0.66

Structure

solution nmr · 2 distinct chains · 53% helix, 2% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACalmodulinprotein14852% helix, 3% strandP62152
BMyosin light chain kinaseprotein2658% helix, 0% strandP07313

Ligands and binding sites

  • CA · Calcium ion · metal · 4 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12110.660.8426empty
24060.580.7536empty
3830.440.8016empty
4540.280.759empty

Interfaces

1 interface between chains.

  • A–B · 1537 Ų buried · 4 hydrogen bonds · protein-protein

Compared structures

  • 2BBN · Solution structure of a calmodulin-target peptide complex by multidimensional NMR · the same entry in another collection · chain A against A, TM-score 1.00
  • P07313 · AlphaFold monomer V2.0 prediction for myosin light chain kinase 2, SKELETAL/CARDIAC… · a predicted model of the same protein · chain B against A, TM-score 0.56
  • P62152 · AlphaFold monomer V2.0 prediction for calmodulin (P62152) · a predicted model of the same protein · chain A against A, TM-score 0.44

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.